In conclusion, polymyxins, as the founding members of LPS-active AMPs, have set the stage for developing novel antibiotics targeting Gram-negative bacteria. Advances in computational and experimental techniques continue to resolve the intricate interactions between polymyxins and bacterial membranes, revealing key insights into their mechanism of action and the development of resistance.